Pneumococcal Vaccine Protects Against Heart Attacks

A study published in the International Journal of Infectious Diseases demonstrated the 23-valent polysaccharide pneumococcal vaccine (PPV23) protects against adverse cardiovascular events, including heart attacks and congestive heart failure, according to a meta-analysis of 18 studies.  

Content Information

Content Author: 
Fawziah Marraa, Angel Zhangb, Emma Gillmanb, Katherine Bessaib, Kamalpreet Parhara. Nirma Vadlamudi

Content Source: 
Science Direct

Content Type: